SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Investment analysts at Zacks Small Cap boosted their Q2 2025 earnings per share (EPS) estimates for SBC Medical Group in a research report issued to clients and investors on Monday, May 19th. Zacks Small Cap analyst M. Marin now anticipates that the company will post earnings per share of $0.14 for the quarter, up from their prior estimate of $0.06. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share. Zacks Small Cap also issued estimates for SBC Medical Group's Q3 2025 earnings at $0.15 EPS, Q4 2025 earnings at $0.15 EPS and FY2025 earnings at $0.65 EPS.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last issued its quarterly earnings data on Thursday, May 15th. The company reported $0.21 EPS for the quarter, topping analysts' consensus estimates of $0.11 by $0.10. The company had revenue of $47.33 million for the quarter, compared to analyst estimates of $51.52 million.
SBC Medical Group Stock Down 1.1%
SBC traded down $0.05 during trading on Thursday, reaching $4.50. The stock had a trading volume of 114,632 shares, compared to its average volume of 58,031. SBC Medical Group has a 1-year low of $2.62 and a 1-year high of $12.50. The stock has a 50 day moving average of $3.57 and a two-hundred day moving average of $4.74. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.76 and a current ratio of 2.79.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Further Reading
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
